Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$2.21M
55K shares
What this filing means
MORTIMER IAN plans to sell 55K shares of XENON PHARMACEUTICALS INC. valued at approximately $2.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/27/2025ACC: 0000950170-25-009384
Officer· PRESIDENT & CFO
Since Sep 2019
55K
Shares to sell
$2.21M
Approx. market value
16.32K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Options
Cash
1/27/2025
16.32KTotal acquired16.32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2025 | Exercise of Options Cash | 16.32K | — |
| Total | 16.32K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
22.47K
Market value
$903.3K
1/24/2025
—Completed
Units to sell
16.22K
Market value
$649.9K
1/23/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.32K
Market value
$660.8K
1/27/2025
Total
Units
55K
Value
$2.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/24/2025 | 22.47K | $903.3K | — | Completed |
1/23/2025 | 16.22K | $649.9K | — | Completed |
| Planned — Approximate Date | ||||
1/27/2025 | 16.32K | $660.8K | NASDAQ | Planned |
| Total | 55K | $2.21M | ||